Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00528099 | Study Evaluating IMA-026 in Healthy Japanese Males | PHASE1 | COMPLETED | 50 | — | — | Oct 1, 2007 | Nov 1, 2008 | Jul 23, 2009 | 1 | Japan |
| NCT00517348 | Study Evaluating IMA-026 in Healthy Subjects | PHASE1 | COMPLETED | 50 | — | — | Sep 1, 2007 | Jul 1, 2008 | Jun 25, 2009 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| IMA-026 | DRUG | SC and IV ascending single doses from lyophilized dosage form 0.3, 1, 2, 4 mg/kg SC and 3 mg/kg IV |
Inclusion Criteria: * Men ages 20 to 40 years, inclusive, at screening * Body mass index (BMI) in the range of 17.6 to 26.4 kg/m2 and body weight \> 45 kg * Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vitals sign...